Moreover, we observed genomic amplification and higher expression of TLK1 and one of its key downstream effector kinases—MK5—in metastatic PCa through our interrogation of TCGA, SU2C, and other public PCa patient databases [15]. Here, MAPKAPK5 is linked to posterior cortical atrophy.